— Know what they know.
Not Investment Advice

CCL vs EXPE vs VIK

161 measures in 16 categories, one definition each, computed from filings and market data.
CCL52.5
Carnival Corporation & plc
Consumer Cyclical · Travel Services
$25.90 −2.12%$34.8B mkt cap
Score DNA
EXPE67.0
Expedia Group, Inc.
Consumer Cyclical · Travel Services
$288.95 −1.00%$33.1B mkt cap
Score DNA
VIK72.6
Viking Holdings Ltd
Consumer Cyclical · Travel Services
$83.42 −0.67%$37.2B mkt cap
Score DNA

Price, rebased to 100 three years ago

CCL   EXPE   VIK   · weekly adjusted closes
100150200250300350400Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26VIK 320EXPE 295CCL 211
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureCCLEXPEVIK
Insider open-market buys, 180d 0 0 0
Insider $ bought, 180d — — —
Congress purchases, 180d 1 2 0
Last Congress purchase 2026-05-01 2026-05-06 —
13F net change in holders +966 +25 +106
ETFs adding shares, 30d 450 1,210 244
ETFs trimming, 30d 334 975 227
Net ETF funds, 30d +116 +235 +17

Valuation

16 measures
MeasureCCLEXPEVIK
P/E (TTM) 11.1x
10th
16.2x
20th
27.6x
60th
PEG (P/E ÷ 3-yr EPS CAGR) — 0.40 —
Price / sales 1.3x
27th
2.1x
36th
5.3x
91st
Price / book 2.5x
14th
27.4x
100th
22.5x
86th
Price / tangible book 2.6x
0th
— 28.4x
100th
Price / free cash flow 11.0x
38th
6.6x
12th
35.6x
88th
Price / operating cash flow 5.1x
18th
6.3x
36th
14.7x
73rd
Enterprise value $58.8B
73rd
$31.6B
55th
$39.4B
64th
EV / sales 2.1x
18th
2.0x
9th
5.7x
91st
EV / EBITDA 8.1x
18th
8.1x
9th
19.7x
73rd
EV / EBIT 13.5x
27th
10.5x
0th
23.3x
73rd
EV / free cash flow 18.5x
50th
6.3x
0th
37.8x
88th
Earnings yield 9.0%
91st
6.2%
82nd
3.6%
45th
FCF yield 9.1%
73rd
15.2%
91st
2.8%
36th
Operating cash flow yield 19.6%
82nd
15.8%
64th
6.8%
27th
Graham number (per share) $23.13
43rd
$60.13
86th
$15.79
29th

Profitability (TTM)

12 measures
MeasureCCLEXPEVIK
Gross margin 34.2%
0th
90.4%
91st
38.8%
27th
EBITDA margin 26.3%
73rd
25.0%
45th
28.7%
82nd
Operating margin 16.0%
45th
18.2%
64th
23.3%
82nd
EBIT margin 15.8%
36th
19.3%
64th
24.2%
82nd
Net margin 11.4%
55th
13.0%
64th
19.3%
73rd
NOPAT margin 16.0%
64th
13.9%
45th
22.9%
82nd
FCF margin 11.5%
45th
32.1%
82nd
15.0%
64th
Operating cash flow margin 24.7%
55th
33.2%
64th
36.2%
82nd
R&D / revenue 0.0%
0th
8.2%
91st
0.0%
0th
SG&A / revenue 13.0%
9th
57.8%
91st
15.5%
18th
Stock comp / revenue 0.4%
0th
2.0%
73rd
0.6%
9th
Effective tax rate -0.1%
0th
23.6%
64th
1.7%
27th

Returns on capital

11 measures
MeasureCCLEXPEVIK
ROE (on average equity) 24.0%
29th
199.1%
100th
139.8%
86th
ROA 6.2%
55th
7.3%
64th
10.8%
91st
ROIC 11.6%
64th
-937.4%
0th
41.3%
100th
ROCE 11.3%
45th
34.7%
91st
22.0%
73rd
Return on tangible assets 8.6%
55th
10.8%
73rd
13.6%
91st
Cash ROIC (OCF / invested capital) 17.9%
25th
— 65.4%
88th
Gross profitability (GP / assets) 18.5%
18th
48.9%
82nd
19.6%
36th
ROIC, 3-yr average 7.4%
43rd
— 32.4%
100th
ROIC, 5-yr average 0.0%
25th
— —
ROE, 5-yr average -9.2%
20th
93.5%
100th
—
Incremental ROIC -404.1%
0th
-314.5%
18th
41.6%
82nd

Growth

17 measures
MeasureCCLEXPEVIK
Revenue growth (TTM YoY) 5.2%
20th
12.0%
60th
20.0%
100th
Revenue growth (QoQ) 26.6%
64th
25.9%
55th
107.9%
91st
Revenue CAGR, 3 yr 11.3%
33rd
8.6%
22nd
—
Revenue CAGR, 5 yr 111.4%
67th
22.1%
11th
—
Gross profit CAGR, 3 yr 18.4%
78th
10.3%
33rd
—
Operating income CAGR, 3 yr 116.1%
100th
33.7%
57th
—
Net income growth (TTM YoY) 18.7%
60th
82.9%
100th
65.8%
90th
Net income CAGR, 3 yr — 31.3%
100th
—
EPS growth (TTM YoY) 21.7%
70th
96.3%
100th
64.9%
90th
EPS CAGR, 3 yr — 40.6%
100th
—
EPS CAGR, 5 yr — — —
FCF growth (TTM YoY) 9.0%
38th
96.9%
88th
34.1%
62nd
FCF CAGR, 3 yr — 29.5%
80th
—
Operating cash flow CAGR, 3 yr 28.1%
75th
18.6%
50th
—
Book value CAGR, 3 yr 27.7%
60th
-5.5%
0th
—
Dividend CAGR, 3 yr — 37.0% —
Sustainable growth rate 19.3%
29th
178.2%
100th
139.8%
86th

Margin history & stability

7 measures
MeasureCCLEXPEVIK
Gross margin, 3-yr average 36.9%
0th
89.6%
90th
39.1%
10th
Operating margin, 3-yr average 15.4%
50th
12.0%
20th
23.9%
80th
Net margin, 3-yr average 9.3%
50th
9.0%
30th
14.4%
70th
FCF margin, 3-yr average 9.2%
30th
21.8%
80th
14.0%
60th
Revenue stability (0-1) 0.86
10th
0.92
50th
0.90
40th
Earnings stability (0-1) 0.91
70th
0.81
40th
1.00
100th
Margin stability (0-1) 0.00
0th
0.94
60th
0.96
80th

Liquidity (latest quarter)

7 measures
MeasureCCLEXPEVIK
Cash & short-term investments $1.2B
64th
$7.1B
82nd
$4.0B
73rd
Net cash (− = net debt) −$23.9B
0th
$1.4B
91st
−$2.2B
45th
Working capital −$9.1B
9th
−$4.1B
27th
−$1.2B
36th
Current ratio 0.27
18th
0.80
27th
0.81
36th
Quick ratio 0.23
18th
0.80
36th
0.79
27th
Cash ratio (cash + ST investments / current liabilities) 0.10
18th
0.35
45th
0.65
64th
Defensive interval (days) 137 days
18th
417 days
45th
1,397 days
100th

Leverage & solvency (latest quarter)

13 measures
MeasureCCLEXPEVIK
Total debt $25.2B
100th
$5.7B
45th
$6.2B
64th
Debt / equity 1.77
43rd
4.70
86th
3.75
71st
Net debt / equity 1.69
71st
−1.19
14th
1.34
57th
Debt / assets 49.4%
45th
19.6%
9th
44.9%
36th
Debt / capital 63.9%
43rd
82.5%
86th
78.9%
71st
Debt / EBITDA 3.46
55th
1.45
9th
3.10
36th
Net debt / EBITDA 3.30
64th
−0.37
9th
1.10
36th
Interest coverage (EBIT / interest) 3.7x
45th
8.5x
82nd
4.8x
55th
Cash interest coverage 5.8x
45th
14.7x
91st
7.2x
73rd
Debt payback (years of OCF) 3.7 yrs
55th
1.1 yrs
9th
2.5 yrs
27th
Liabilities / assets 72.1%
9th
91.5%
64th
88.0%
45th
IS credit model rating BB A- BBB-
Implied credit spread (bps) 475
55th
175
18th
350
36th

Efficiency

11 measures
MeasureCCLEXPEVIK
Asset turnover 0.54
45th
0.56
64th
0.56
55th
Fixed asset turnover 0.62
20th
5.80
60th
0.80
30th
Inventory turnover 36.2
33rd
— 42.2
83rd
Receivables turnover 41.8
70th
2.9
0th
54.3
90th
Days sales outstanding 9 days
36th
125 days
100th
7 days
18th
Days inventory outstanding 10 days
67th
— 9 days
17th
Days payables outstanding 23 days
30th
867 days
100th
26 days
50th
Cash conversion cycle (days) −5 days
70th
−743 days
0th
−11 days
50th
Capex / revenue 13.2%
60th
1.1%
0th
21.2%
80th
Capex / depreciation 1.26
40th
0.19
0th
4.77
100th
Operating expense ratio 18.8%
9th
66.8%
91st
12.3%
0th

Cash flow & earnings quality

7 measures
MeasureCCLEXPEVIK
Operating cash flow / net income 2.17
50th
2.56
60th
1.87
30th
FCF / net income 1.01
40th
2.48
70th
0.78
30th
FCF / operating cash flow 46.6%
40th
96.7%
90th
41.4%
30th
Capex / operating cash flow 53.4%
60th
3.3%
10th
58.6%
70th
Accruals ratio -7.2%
64th
-11.3%
9th
-9.4%
18th
Sloan accruals ratio -8.6%
9th
-0.3%
55th
3.7%
73rd
Earnings quality score (0-1) 0.75
0th
0.75
0th
0.75
0th

Dividends & buybacks

9 measures
MeasureCCLEXPEVIK
Dividend yield 1.7%
82nd
0.6%
64th
0.0%
0th
Dividend per share (TTM) $0.45
64th
$1.84
82nd
$0.00
0th
Payout ratio (dividends / net income) 19.7%
90th
10.5%
60th
0.0%
0th
Dividends / FCF 19.5%
88th
4.2%
62nd
0.0%
0th
Dividend growth (YoY) — 125.1%
100th
—
Buyback yield 1.6%
30th
5.8%
80th
0.0%
0th
Shareholder yield (dividends + buybacks) 3.3%
40th
6.4%
80th
0.0%
0th
Share count change (YoY) -2.4%
50th
-6.8%
20th
0.6%
80th
Buybacks, last 5 years $548.0M
45th
$9.7B
82nd
$0
0th

Scores & forensic checks

15 measures
MeasureCCLEXPEVIK
IS score 53
55th
67
73rd
73
82nd
IS profitability 73
55th
78
64th
81
100th
IS growth 58
60th
89
100th
88
90th
IS value 75
100th
53
73rd
32
18th
IS momentum 84
60th
92
80th
97
100th
IS risk (safety) 30
27th
30
27th
80
73rd
IS quality 74
91st
68
55th
65
36th
IS balance sheet 31
27th
56
64th
50
55th
IS earnings quality 83
73rd
52
9th
79
55th
IS cash flow 55
45th
94
100th
64
64th
Piotroski F-score (0-9) 7
55th
9
100th
7
55th
Altman Z-score 1.3
27th
1.5
36th
3.1
73rd
Beneish M-score −2.76
64th
−2.82
55th
−3.09
9th
Ohlson O-score −7.01
18th
−5.99
55th
−6.04
45th
IS credit score 45
45th
65
73rd
53
64th

Per share

7 measures
MeasureCCLEXPEVIK
EPS, diluted (TTM) $2.29
45th
$16.45
100th
$3.01
55th
Book value per share $10.37
73rd
$9.77
64th
$3.69
36th
Tangible book per share $9.13
73rd
−$44.87
0th
$3.70
55th
Revenue per share $20.17
45th
$126.86
100th
$15.55
27th
FCF per share $2.32
55th
$40.76
100th
$2.33
64th
Operating cash flow per share $4.99
45th
$42.15
100th
$5.63
55th
Cash per share $0.89
9th
$57.59
100th
$8.89
73rd

Size (TTM)

8 measures
MeasureCCLEXPEVIK
Market cap $34.8B
64th
$33.1B
55th
$37.2B
73rd
Revenue $27.6B
91st
$15.7B
73rd
$7.0B
45th
EBITDA $7.3B
91st
$3.9B
73rd
$2.0B
45th
Net income $3.1B
82nd
$2.0B
64th
$1.3B
55th
Free cash flow $3.2B
73rd
$5.0B
91st
$1.0B
64th
Total assets $51.0B
100th
$29.1B
73rd
$13.8B
45th
Shareholders' equity $14.2B
100th
$1.2B
55th
$1.7B
64th
Employees 160,000
100th
16,000
55th
13,000
45th

Price performance

9 measures
MeasureCCLEXPEVIK
1 day −2.1% −1.0% −0.7%
1 week −1.7% +5.4% +2.2%
1 month +16.8% +1.6% −1.7%
3 months −0.5% +9.2% −13.9%
6 months −11.4% +9.1% −2.8%
Year to date −15.8% +2.7% +15.4%
1 year −10.2% +33.3% +35.1%
3 years, cumulative +104.7% +182.8% —
5 years, cumulative +8.7% +72.3% —

Technicals

4 measures
MeasureCCLEXPEVIK
RSI 14 56.5 58.5 50.6
From 52-week high −23.5% −15.4% −24.2%
From 52-week low +20.8% +56.8% +48.0%
Beta 2.38 1.36 1.47
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms